Browse the evidence

Comorbidities including obesity (48.6%), hypertension (54.7%), and hypercholesterolemia (31.6%) are highly prevalent in Korean adults with diabetes, yet control rates for these conditions are suboptimal.

Diabetes rarely comes alone. Nearly half of diabetic adults are obese, and more than half have high blood pressure. Managing your weight and diet is crucial not just for blood sugar, but for controlling blood pressure and cholesterol, which together determine your heart health.

In obesity, chronic low-grade inflammation in brown and beige adipose tissue impairs thermogenic activity and glucose uptake, contributing to metabolic syndrome.

Obesity triggers inflammation in fat tissue that shuts down its ability to burn energy and process sugar. This isn't just about calories in vs. out; it's about the tissue's health. Reducing inflammation through healthy lifestyle choices may help restore the function of brown and beige fat, improving metabolic flexibility.

Pro-inflammatory cytokines, particularly TNFα, impair brown adipose tissue thermogenesis by reducing UCP1 expression and insulin sensitivity.

High levels of inflammatory markers in the body can directly interfere with your brown fat's ability to burn calories and process glucose. Managing systemic inflammation is key to maintaining metabolic health.

Inflammation in perivascular adipose tissue (PVAT) and epicardial adipose tissue (eAT) promotes cardiovascular damage by releasing pro-inflammatory signals and reducing vasoprotective brown adipokines.

Fat stored around your heart and blood vessels isn't just inert storage; it actively communicates with your cardiovascular system. Inflammation in this fat can damage blood vessels and increase heart disease risk. Reducing overall body fat and inflammation may protect your heart.

Age-related insulin resistance in older adults is primarily driven by increased visceral adiposity and central fat distribution rather than aging itself, as accounting for body fat and distribution eliminates age as a predictor of insulin action.

Focus on maintaining a healthy body weight and minimizing visceral fat through diet and exercise. This is more critical for metabolic health in older age than simply accepting 'aging' as the cause of metabolic issues.

Obesity-associated cardiovascular risk is driven by adipose tissue dysfunction and altered adipokine secretion (specifically increased leptin/resistin and decreased adiponectin/omentin-1), rather than body mass index (BMI) alone.

If you have obesity, your risk for heart disease is heavily influenced by the hormones your fat cells release, not just your weight. Visceral fat is particularly harmful because it releases pro-inflammatory signals (like leptin and resistin) and fewer protective signals (like adiponectin). While weight loss helps, interventions that improve metabolic health (like bariatric surgery) work partly by restoring this hormonal balance, not just by reducing mass.

Leptin resistance in obesity reverses its protective vascular effects, contributing to a pro-oxidative state, endothelial dysfunction, and accelerated biological senescence.

In obesity, high leptin levels do not protect the heart because the body becomes resistant to them. This resistance allows leptin to promote oxidative stress and endothelial dysfunction, increasing cardiovascular risk. Restoring leptin sensitivity (e.g., through weight loss or bariatric surgery) may help restore these protective vascular effects.

Bariatric surgery improves cardiovascular risk profiles by significantly altering adipokine secretion profiles, specifically decreasing leptin and increasing adiponectin, independent of simple caloric restriction.

Bariatric surgery is effective not just because it reduces stomach size, but because it fundamentally changes the hormones your fat cells release. It lowers leptin (reducing resistance) and raises adiponectin (improving insulin sensitivity and reducing inflammation), which collectively improve cardiovascular risk.

Higher genetic liability for GrimAge acceleration (a DNA methylation-based biomarker of biological aging) is causally associated with greater adiposity, current tobacco smoking, and lower educational attainment, while being inversely associated with parental longevity.

Your biological age, measured by DNA methylation patterns (GrimAge), is strongly linked to your weight, smoking status, and education level. Maintaining a healthy weight and avoiding smoking can significantly slow down this specific marker of biological aging, potentially extending healthspan and longevity.

Genetic variants associated with Intrinsic Epigenetic Age Acceleration (IEAA) are enriched in pathways related to lipid metabolism, immune function, and hematopoietic stem cell properties, independent of DNA methylation levels at the clock's constituent CpG sites.

Research shows that your genetic makeup influences how your body ages through immune and lipid pathways. While you cannot change your genes, understanding these links highlights the importance of managing inflammation and lipid levels for healthy aging.

Intermittent hypoxia (IH) characteristic of obstructive sleep apnea causes hypertension by dysregulating Hypoxia-Inducible Factors (HIF-1α and HIF-2α), which increases reactive oxygen species (ROS) to activate the sympathetic nervous system and impair baroreflex function.

If you have sleep apnea, the repeated drops in oxygen during sleep trigger a chemical response (HIF/ROS) that keeps your nervous system in 'fight or flight' mode, raising blood pressure even when you are awake. Treating the apnea (e.g., with CPAP) is critical, but because this chemical signaling can persist or cause vascular remodeling, blood pressure may not return to normal without additional targeted interventions. Managing OSA is not just about breathing; it is about stopping the chemical signal that drives hypertension.

Intermittent hypoxia causes insulin resistance and Type 2 Diabetes by increasing ROS in pancreatic beta cells via HIF-1α, leading to hypersecretion of insulin and eventual beta-cell dysfunction.

Sleep apnea doesn't just affect your heart; it stresses your pancreas. The repeated oxygen drops trigger a response (HIF-1/ROS) that forces your beta cells to overwork and secrete too much insulin, leading to insulin resistance and Type 2 Diabetes. Treating your sleep apnea is essential to protect your metabolic health, not just your blood pressure.

Intermittent hypoxia causes cognitive decline and memory impairment by increasing ROS in the hippocampus via HIF-1α, which downregulates NMDA receptors and disrupts synaptic plasticity.

Sleep apnea can physically change your brain's memory centers. The oxygen drops trigger a chemical response (HIF-1/ROS) that damages the connections (NMDA receptors) needed for learning and memory. This isn't just 'brain fog' from being tired; it's structural damage to the hippocampus. Treating OSA may help prevent further cognitive decline.

Short-term high-dose supplementation with Fructooligosaccharides (FOS) or Galactooligosaccharides (GOS) in healthy young adults causes adverse glycemic metabolism by reducing butyrate-producing bacteria.

If you are healthy, taking high doses of FOS or GOS (16g/day) for short periods might actually worsen your blood sugar response. This contradicts the common belief that prebiotics always help glucose control. The effect is linked to a drop in butyrate-producing bacteria.

FOS and GOS supplementation increases Bifidobacterium abundance but decreases butyrate-producing bacteria (Phascolarctobacterium, Ruminococcus), which correlates with impaired glucose tolerance.

Prebiotics don't just feed 'good' bacteria; they can also suppress other beneficial bacteria that produce butyrate, which is crucial for glucose control. This suggests prebiotics are not universally beneficial for metabolic health.

Maternal overweight/obesity increases the risk of childhood overweight/obesity, with the magnitude of risk being significantly higher for cesarean-delivered infants compared to vaginally delivered infants, mediated sequentially by birth mode and infant gut microbiota (specifically Firmicutes richness and Lachnospiraceae abundance).

For mothers with overweight or obesity, be aware that both vaginal and cesarean delivery carry an increased risk of childhood overweight compared to normal-weight mothers, with cesarean delivery showing a higher risk. This risk is partly mediated by the infant's gut microbiota, specifically the abundance of Lachnospiraceae. While birth mode cannot be changed post-delivery, understanding this link highlights the importance of early gut health. Postnatal factors such as breastfeeding, diet, and antibiotic exposure also shape the microbiome and may offer opportunities to mitigate risk.

Excessive extracellular matrix (ECM) remodeling and collagen accumulation in adipose tissue causes fibrosis, which restricts adipocyte expansion, triggers hypoxia and inflammation, and directly leads to insulin resistance.

For those with obesity and insulin resistance, simply losing weight may not be enough if adipose tissue fibrosis is present. Strategies that promote healthy adipose tissue expansion (like moderate, sustained weight loss rather than rapid fluctuations) and reduce inflammation may help preserve tissue elasticity. Resistance training is mentioned as potentially modulating ECM components (MMP-2, VEGF-A, TIMP-2), suggesting it may support healthier adipose tissue structure.

Industrial trans fatty acids stimulate cholesterol synthesis in the liver by activating SREBP2-mediated gene regulation, leading to increased hepatic cholesterol concentrations and steatosis.

Consuming industrial trans fats may cause your liver to overproduce cholesterol by activating specific genes (SREBP2), contributing to fatty liver and high blood cholesterol levels.

Obesity-associated inflammation is driven by tissue-resident and recruited immune cells (specifically Th1, Th17, CD8+, and gamma-delta T cells) in adipose tissue, liver, and gut, creating a feed-forward loop of metabolic decline and comorbidities.

Obesity is not just about calories; it triggers a chronic inflammatory state in fat, liver, and gut tissues. This inflammation is driven by specific immune cells (like T cells) that release inflammatory signals, worsening insulin resistance and metabolic health. Managing obesity requires addressing this inflammatory component, not just weight loss.

Continuous hyperinsulinemia (loss of pulsatile secretion) directly causes insulin resistance by downregulating insulin receptors and impairing downstream signaling.

Avoid constant snacking or continuous nutrient intake to preserve pulsatile insulin secretion. Pulsatile secretion is essential for maintaining insulin sensitivity and preventing receptor downregulation.

Global efforts to reduce malnutrition have been more than offset by a rapidly rising obesity burden, resulting in a widening 'double burden' of disease where obesity-related disability-adjusted life years (DALYs) now vastly exceed malnutrition-related DALYs.

Global health strategies must stop treating hunger and obesity as separate issues. As countries develop and reduce starvation, they often swing into obesity epidemics. Effective policy requires a unified approach that ensures food security while simultaneously preventing the shift toward unhealthy, obesity-driving diets, particularly in low-to-middle income regions undergoing rapid economic change.

Obesity-related mortality and DALYs are highest in low-to-middle Socio-Demographic Index (SDI) countries, whereas malnutrition burden is concentrated in low SDI countries, creating a distinct geographic and socioeconomic split in the double burden of disease.

Public health in developing nations must anticipate the 'nutrition transition.' As economies grow, access to food increases, but often shifts toward unhealthy, obesity-driving diets. Policies must simultaneously address undernutrition and prevent the rise of obesity, as the burden of obesity-related death peaks in middle-income countries, not the wealthiest ones.

Small nucleolar size is a conserved cellular hallmark of longevity and metabolic health across multiple species, including C. elegans, Drosophila, mice, and humans.

This research identifies small nucleoli as a marker of longevity and metabolic health. While you cannot directly 'exercise' your nucleoli, interventions that promote longevity—such as dietary restriction and exercise—are associated with this cellular feature. For humans, combining modest caloric restriction with increased physical activity was linked to smaller nucleoli in muscle biopsies, suggesting this cellular change is a reversible marker of metabolic improvement.

GLP-1 analogs exert pleiotropic effects on multiple tissues beyond glucose regulation, including neuroprotection, cardiac improvement, and metabolic reprogramming, mediated by cAMP/PKA/EPAC signaling pathways.

GLP-1 analogs (like semaglutide or liraglutide) are not just for blood sugar. They work by mimicking a natural hormone to signal your brain, heart, and gut. This leads to reduced appetite, better heart function, and potential protection for your brain and kidneys. Consistency is key because these benefits build over time through sustained receptor activation.